Company: HCTI
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-027277
Chunk: 18

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 18
---
 Purchase Agreement.

Pursuant to the Purchase Agreement,
the Company has also agreed that until one hundred and eighty (180) days after the effective date of the registration statement, the Company
and any of its subsidiaries shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or
any of its subsidiaries of shares of Common Stock or Common Stock equivalents (or a combination of units thereof) involving a Variable
Rate Transaction, subject to certain exception set forth in the Purchase Agreement.

“Variable Rate Transaction”
means a transaction in which the Company (i) issues or sells any shares of Common Stock or Common Stock equivalents either (A) at a conversion
price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for
the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise
or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon
the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common
Stock, other than in connection with customary anti-dilution adjustments resulting from future stock splits, stock dividends or similar
transactions, or (ii) issues or sells any amortizing convertible security that amortizes prior to its maturity date, whereby it is required
to or has the option to (or the investor in such security has the option to require the Company to) make such amortization payments in
Common Stock (whether or not such payments in stock are subject to certain equity conditions) or (iii) enters into, or effects a transaction
under, any agreement, including, but not limited to, an equity line of credit or “at-the-market” offering, whereby it may
sell securities at a future determined price, regardless of whether shares of Common Stock pursuant to such agreement have actually been
issued and regardless of whether such agreement is subsequently canceled, provided that any issuance of Shares (1) issued in connection
with the Securities Purchase Agreement dated December 28, 2023 between the Company and L1 Capital Global Opportunities Master Fund Ltd
or any of the transaction documents related thereto (collectively, The “L1 Transaction Documents”) excluding any amendments
or restatements of such L1 Transaction Documents or (2) upon the exercise of the Purchase Warrants will not be deemed a Variable Rate
Transaction.

The